Course of Disease and Clinical Management of Patients with Poorly Differentiated Thyroid Carcinoma.
Freba GraweAtika CahyaMatthias Philipp FabritiusLeonie BeyerVera WenterJohannes RübenthalerThomas GeyerCaroline Alexandra BurgardPeter BartensteinHarun IlhanChristine SpitzwegAndrei TodicaPublished in: Cancers (2021)
The response to initial surgery and radioiodine therapy in PDTC patients can achieve an excellent outcome and a further follow-up should be refined based on findings at the first diagnostic control. However, patients with an incomplete response and metastatic patients who become mostly radioiodine refractory show a significantly shorter survival, which makes accurate staging by 18F-FDG-PET/CT imaging crucial.
Keyphrases
- end stage renal disease
- minimally invasive
- ejection fraction
- small cell lung cancer
- newly diagnosed
- squamous cell carcinoma
- chronic kidney disease
- prognostic factors
- peritoneal dialysis
- lymph node
- stem cells
- mesenchymal stem cells
- coronary artery disease
- patient reported outcomes
- acute coronary syndrome
- bone marrow
- percutaneous coronary intervention
- surgical site infection
- cell therapy
- replacement therapy